Roche报告2024年销售额增长7%,净收入下降19%,预测2025年的增长。 Roche reports 2024 sales up 7%, net income down 19%, forecasts growth for 2025.

瑞士一家制药公司Roche报告说,2024年销售额增长7%,达到605亿瑞士法郎,尽管由于减值费用,净收入下降19%,达到92亿瑞士法郎。 Roche, a Swiss pharmaceutical company, reported a 7% increase in sales to 60.5 billion Swiss francs in 2024, despite a 19% drop in net income to 9.2 billion Swiss francs due to impairment charges. 核心业务利润增长了14%,达到208亿法郎。 Core operating profit rose by 14% to 20.8 billion francs. Roche预测2025年销售额的中位数增长和每股核心收入的高位数增长。 For 2025, Roche forecasts mid-single-digit growth in sales and a high-single-digit increase in core earnings per share.